{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T21:04:49Z","timestamp":1783544689311,"version":"3.55.0"},"reference-count":74,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2013,4,24]],"date-time":"2013-04-24T00:00:00Z","timestamp":1366761600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Hepatology Research"],"published-print":{"date-parts":[[2014,1]]},"abstract":"<jats:p>Depression is a frequent side\u2010effect of interferon\u2010based treatment of patients with chronic viral hepatitis, that may lead to reduction or discontinuation of treatment. Clinical trials data showed the importance of therapy of psychiatric disorders for a successful antiviral treatment. Emerging evidence suggests that interferon may cause depression affecting serotonin synthesis via increased activity of indoleamine 2,3\u2010dioxygenase. Serotonin reuptake inhibitors significantly improve mood disorders, but the use of these drugs requires caution because some studies reported the emergence of mania in patients treated for depression during antiviral therapy. Therefore, this review will examine and discuss the putative role of serotonin and its metabolism in the development of depression during antiviral therapy, focusing on pharmacological interventions to reduce side\u2010effects.<\/jats:p>","DOI":"10.1111\/hepr.12116","type":"journal-article","created":{"date-parts":[[2013,3,25]],"date-time":"2013-03-25T07:56:45Z","timestamp":1364198205000},"page":"9-16","source":"Crossref","is-referenced-by-count":10,"title":["Serotonin and its implication in the side\u2010effects of interferon\u2010based treatment of patients with chronic viral hepatitis: Pharmacological interventions"],"prefix":"10.1111","volume":"44","author":[{"given":"Cristina","family":"Stasi","sequence":"first","affiliation":[{"name":"Department of Internal Medicine University of Florence  Florence Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Rosselli","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine University of Florence  Florence Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Linda","family":"Zignego","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine University of Florence  Florence Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giacomo","family":"Laffi","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine University of Florence  Florence Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Milani","sequence":"additional","affiliation":[{"name":"Department of Clinical Pathophysiology University of Florence  Florence Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2013,4,24]]},"reference":[{"key":"e_1_2_5_2_1","doi-asserted-by":"publisher","DOI":"10.2190\/D37Y-X0JY-39MJ-PVXQ"},{"key":"e_1_2_5_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2012.01.018"},{"key":"e_1_2_5_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.genhosppsych.2011.09.002"},{"key":"e_1_2_5_5_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2893.2003.00416.x"},{"key":"e_1_2_5_6_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.20635"},{"key":"e_1_2_5_7_1","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000240255.42608.99"},{"key":"e_1_2_5_8_1","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.78.10.5170-5183.2004"},{"key":"e_1_2_5_9_1","doi-asserted-by":"publisher","DOI":"10.1086\/526519"},{"key":"e_1_2_5_10_1","doi-asserted-by":"publisher","DOI":"10.1099\/vir.0.19491-0"},{"key":"e_1_2_5_11_1","first-page":"5","article-title":"Effectiveness and tolerability of pegylated interferon alfa\u20102b in combination with ribavirin for treatment of chronic hepatitis C: the PegIntrust study","volume":"73","author":"VanVlierberghe H","year":"2010","journal-title":"Acta Gastroenterol Belg"},{"key":"e_1_2_5_12_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11901-010-0041-7"},{"key":"e_1_2_5_13_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1746.2011.06965.x"},{"key":"e_1_2_5_14_1","first-page":"362","article-title":"Benefits of a preventive psychiatric accompaniment in patients hepatitis C virus seropositive (HCV): prospective study concerning 39 patients","volume":"29","author":"Lang JP","year":"2003","journal-title":"Encephale"},{"key":"e_1_2_5_15_1","doi-asserted-by":"publisher","DOI":"10.1002\/hup.609"},{"key":"e_1_2_5_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.yfrne.2008.10.001"},{"key":"e_1_2_5_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuro.2009.03.004"},{"key":"e_1_2_5_18_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2893.2010.01418.x"},{"key":"e_1_2_5_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2007.11.001"},{"key":"e_1_2_5_20_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1990.01810170011002"},{"key":"e_1_2_5_21_1","first-page":"28","article-title":"Acute tryptophan depletion: a method of studying antidepressant action","volume":"53","author":"Miller HL","year":"1992","journal-title":"J Clin Psychiatry"},{"key":"e_1_2_5_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2010.10.009"},{"key":"e_1_2_5_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbi.2012.05.010"},{"key":"e_1_2_5_24_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2000.03177.x"},{"key":"e_1_2_5_25_1","first-page":"S25","article-title":"Serotonin and its implication for the management of irritable bowel syndrome","volume":"3","author":"Gershon MD","year":"2003","journal-title":"Rev Gastroenterol Disord"},{"key":"e_1_2_5_26_1","doi-asserted-by":"publisher","DOI":"10.1002\/hbm.20035"},{"key":"e_1_2_5_27_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.83.24.9799"},{"key":"e_1_2_5_28_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-4159.1993.tb03522.x"},{"key":"e_1_2_5_29_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-0348-8391-7_3"},{"key":"e_1_2_5_30_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.1123842"},{"key":"e_1_2_5_31_1","doi-asserted-by":"publisher","DOI":"10.1002\/prot.22819"},{"key":"e_1_2_5_32_1","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.02248-06"},{"key":"e_1_2_5_33_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.mp.4001141"},{"key":"e_1_2_5_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2011.08.027"},{"key":"e_1_2_5_35_1","doi-asserted-by":"publisher","DOI":"10.2174\/187152411798047762"},{"key":"e_1_2_5_36_1","first-page":"235","article-title":"MAO\u2010A and \u2010B gene knockout distinctly different behavior","volume":"7","author":"Shih JC","year":"1999","journal-title":"Neurobiology (Bp)"},{"key":"e_1_2_5_37_1","doi-asserted-by":"publisher","DOI":"10.1254\/jjp.46.147"},{"key":"e_1_2_5_38_1","doi-asserted-by":"publisher","DOI":"10.1023\/A:1003431122334"},{"key":"e_1_2_5_39_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2893.2005.00706.x"},{"key":"e_1_2_5_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-3223(03)00173-2"},{"key":"e_1_2_5_41_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.mp.4000872"},{"key":"e_1_2_5_42_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-200202000-00014"},{"key":"e_1_2_5_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1590-8658(07)80021-1"},{"key":"e_1_2_5_44_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1471-4159.1996.66062621.x"},{"key":"e_1_2_5_45_1","doi-asserted-by":"publisher","DOI":"10.1097\/00041444-200409000-00001"},{"key":"e_1_2_5_46_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2004.11.027"},{"key":"e_1_2_5_47_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2008.08.009"},{"key":"e_1_2_5_48_1","first-page":"137","article-title":"A functional serotonin transporter gene polymorphism and depressive effects associated with interferon\u2010alpha treatment","volume":"51","author":"Pierucci\u2010Lagha A","year":"2010","journal-title":"Psychosomatics"},{"key":"e_1_2_5_49_1","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.2006.163.9.1588"},{"key":"e_1_2_5_50_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-2999(96)00968-5"},{"key":"e_1_2_5_51_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2009.10.007"},{"key":"e_1_2_5_52_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(01)06102-5"},{"key":"e_1_2_5_53_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2012.11.020"},{"key":"e_1_2_5_54_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(11)60007-X"},{"key":"e_1_2_5_55_1","doi-asserted-by":"publisher","DOI":"10.2165\/00044011-200626110-00005"},{"key":"e_1_2_5_56_1","doi-asserted-by":"publisher","DOI":"10.1592\/phco.24.16.1546.50947"},{"issue":"8","key":"e_1_2_5_57_1","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1177\/135965350601100814","article-title":"Outcome of chronic hepatitis C patients who required early termination of pegylated interferon\u2010alpha plus ribavirin combination therapy","volume":"11","author":"Yu ML","year":"2006","journal-title":"Antivir Ther"},{"issue":"3","key":"e_1_2_5_58_1","first-page":"273","article-title":"Reflections on the treatment of EDM in hepatitis C virus patients treated with interferon alpha from a retrospective survey concerning 29 patients","volume":"29","author":"Lang JP","year":"2003","journal-title":"Encephale"},{"key":"e_1_2_5_59_1","doi-asserted-by":"publisher","DOI":"10.5694\/j.1326-5377.2000.tb125687.x"},{"key":"e_1_2_5_60_1","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2007.131607"},{"key":"e_1_2_5_61_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2011.04867.x"},{"key":"e_1_2_5_62_1","doi-asserted-by":"publisher","DOI":"10.4088\/PCC.v04n0107"},{"key":"e_1_2_5_63_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.21791"},{"key":"e_1_2_5_64_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2005.01.020"},{"key":"e_1_2_5_65_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0033-3182(10)70722-2"},{"key":"e_1_2_5_66_1","unstructured":"National Institute for Health and Clinical Excellence.Depression: the treatment and management of depression in adults. (update). Final draft October2009. Available at:http:\/\/www.nice.org.uk\/nicemedia\/pdf\/Depression_Update_FULL_GUIDELINE.pdf. Accessed October 2009."},{"key":"e_1_2_5_67_1","volume-title":"Kaplan and Sadock's Synopsis of Psychiatry: Behavioral Sciences Clinical Psychiatry","author":"Kaplan HI","year":"1994"},{"key":"e_1_2_5_68_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2012.07.037"},{"key":"e_1_2_5_69_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.161.3.429"},{"key":"e_1_2_5_70_1","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(20000715)89:2<356::AID-CNCR21>3.0.CO;2-Z"},{"key":"e_1_2_5_71_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.genhosppsych.2007.04.006"},{"key":"e_1_2_5_72_1","unstructured":"EASL.2012.Interferon lambda beats alfa in clearing HCV genotype 2 or 3. From Medscape Medical News. Available at:http:\/\/hepatitiscresearchandnewsupdates.blogspot.it\/2012\/04\/easl\u20102012\u2010interferon\u2010lambda\u2010beats\u2010alfa.html. Accessed April 27 2012."},{"key":"e_1_2_5_73_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.21683"},{"key":"e_1_2_5_74_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-007-0129-2"},{"key":"e_1_2_5_75_1","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.50.5767"}],"container-title":["Hepatology Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fhepr.12116","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/hepr.12116","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,2]],"date-time":"2023-10-02T22:50:13Z","timestamp":1696287013000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/hepr.12116"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4,24]]},"references-count":74,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,1]]}},"alternative-id":["10.1111\/hepr.12116"],"URL":"https:\/\/doi.org\/10.1111\/hepr.12116","archive":["Portico"],"relation":{},"ISSN":["1386-6346","1872-034X"],"issn-type":[{"value":"1386-6346","type":"print"},{"value":"1872-034X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,4,24]]}}}